ASX-listed ResApp Health will partner with Brisbane-headquartered telehealth provider Phenix Health to integrate ResApp’s acute respiratory diagnostic test into Phenix’s telehealth app.

ResApp has recently completed a similar integration of ResAppDx-EU into Coviu’s telehealth platform and is expecting to have it available for use in a few months. The company is also about to launch a consumer-focused smartphone app for sleep apnoea.